EXPLORing Arthritis with Total-body Positron Emission Tomography

Overview

Journal Semin Musculoskelet Radiol

Publisher Thieme

Specialties Orthopedics
Physiology
Radiology

Date 2023 Nov 7

PMID 37935209

Authors

Abhijit J Chaudhari

Yasser G Abdelhafez

Lorenzo Nardo

Siba P Raychaudhuri

Affiliations

Soon will be listed here.

Abstract

Arthritis has significant adverse consequences on musculoskeletal tissues and often other organs of the body. Current methods for clinical evaluation of arthritis are suboptimal, and biomarkers that are objective and measurable indicators for monitoring of arthritis disease activity are in critical demand. Recently, total-body positron emission tomography (PET) has been developed that can collect imaging signals synchronously from the entire body at ultra-low doses and reduced scan times. These scanners have increased signal collection efficiency that overcomes several limitations of standard PET scanners in the evaluation of arthritis, and they may potentially provide biomarkers to assess local and systemic impact of the arthritis disease process. This article reviews current results from using total-body PET in the assessment of common arthritic conditions, and it outlines future opportunities and challenges.

Citing Articles

Role of Total Body PET/CT in Inflammatory Disorders.

Zoghi S, Mingels C, Badawi R, Spencer B, Yarbrough T, Nardo L Semin Nucl Med. 2024; 55(1):41-51.

PMID: 39578110 PMC: 11645246. DOI: 10.1053/j.semnuclmed.2024.11.001.

References

Husic R, Gretler J, Felber A, Graninger W, Duftner C, Hermann J . Disparity between ultrasound and clinical findings in psoriatic arthritis. Ann Rheum Dis. 2013; 73(8):1529-36. DOI: 10.1136/annrheumdis-2012-203073. View

Hammer H, Michelsen B, Sexton J, Haugen I, Provan S, Haavardsholm E . Swollen, but not tender joints, are independently associated with ultrasound synovitis: results from a longitudinal observational study of patients with established rheumatoid arthritis. Ann Rheum Dis. 2019; 78(9):1179-1185. DOI: 10.1136/annrheumdis-2019-215321. View

Hunter D, Collins J, Deveza L, Hoffmann S, Kraus V . Biomarkers in osteoarthritis: current status and outlook - the FNIH Biomarkers Consortium PROGRESS OA study. Skeletal Radiol. 2023; 52(11):2323-2339. PMC: 10509067. DOI: 10.1007/s00256-023-04284-w. View

Harnden K, Pease C, Jackson A . Rheumatoid arthritis. BMJ. 2016; 352:i387. DOI: 10.1136/bmj.i387. View

Li E, Spencer B, Schmall J, Abdelhafez Y, Badawi R, Wang G . Efficient Delay Correction for Total-Body PET Kinetic Modeling Using Pulse Timing Methods. J Nucl Med. 2021; 63(8):1266-1273. PMC: 9364346. DOI: 10.2967/jnumed.121.262968. View

Singla S, Eder L, Kaeley G, Aydin S . The Use and Availability of Musculoskeletal Ultrasonography for Psoriatic Disease Among Group for Research and Assessment of Psoriasis and Psoriatic Arthritis Members and the Unmet Needs. Clin Ther. 2023; 45(9):822-825. DOI: 10.1016/j.clinthera.2023.06.005. View

Hu P, Zhang Y, Yu H, Chen S, Tan H, Qi C . Total-body F-FDG PET/CT scan in oncology patients: how fast could it be?. Eur J Nucl Med Mol Imaging. 2021; 48(8):2384-2394. DOI: 10.1007/s00259-021-05357-5. View

Narayan N, Owen D, Taylor P . Advances in positron emission tomography for the imaging of rheumatoid arthritis. Rheumatology (Oxford). 2017; 56(11):1837-1846. DOI: 10.1093/rheumatology/kew484. View

Mannheim J, Rausch I, Conti M, Fougere C, Schmidt F . Characterization of the partial volume effect along the axial field-of-view of the Biograph Vision Quadra total-body PET/CT system for multiple isotopes. EJNMMI Phys. 2023; 10(1):33. PMC: 10224893. DOI: 10.1186/s40658-023-00554-7. View

10.

Roivainen A, Parkkola R, Yli-Kerttula T, Lehikoinen P, Viljanen T, Mottonen T . Use of positron emission tomography with methyl-11C-choline and 2-18F-fluoro-2-deoxy-D-glucose in comparison with magnetic resonance imaging for the assessment of inflammatory proliferation of synovium. Arthritis Rheum. 2003; 48(11):3077-84. DOI: 10.1002/art.11282. View

11.

Verweij N, Yaqub M, Bruijnen S, Pieplenbosch S, Ter Wee M, Jansen G . First in man study of [F]fluoro-PEG-folate PET: a novel macrophage imaging technique to visualize rheumatoid arthritis. Sci Rep. 2020; 10(1):1047. PMC: 6978456. DOI: 10.1038/s41598-020-57841-x. View

12.

Krabbe S, Eshed I, Gandjbakhch F, Pedersen S, Bird P, Mathew A . Development and Validation of an OMERACT MRI Whole-Body Score for Inflammation in Peripheral Joints and Entheses in Inflammatory Arthritis (MRI-WIPE). J Rheumatol. 2019; 46(9):1215-1221. DOI: 10.3899/jrheum.181084. View

13.

Watanabe T, Takase-Minegishi K, Ihata A, Kunishita Y, Kishimoto D, Kamiyama R . (18)F-FDG and (18)F-NaF PET/CT demonstrate coupling of inflammation and accelerated bone turnover in rheumatoid arthritis. Mod Rheumatol. 2015; 26(2):180-7. DOI: 10.3109/14397595.2015.1069458. View

14.

Poggenborg R, Pedersen S, Eshed I, Sorensen I, Moller J, Madsen O . Head-to-toe whole-body MRI in psoriatic arthritis, axial spondyloarthritis and healthy subjects: first steps towards global inflammation and damage scores of peripheral and axial joints. Rheumatology (Oxford). 2014; 54(6):1039-49. DOI: 10.1093/rheumatology/keu439. View

15.

Park H, Chang S, Lee J, Lee S . Clinical utility of F-18 sodium fluoride PET/CT for estimating disease activity in patients with rheumatoid arthritis. Quant Imaging Med Surg. 2021; 11(4):1156-1169. PMC: 7930669. DOI: 10.21037/qims-20-788. View

16.

Chaudhari A, Bowen S, Burkett G, Packard N, Godinez F, Joshi A . High-resolution (18)F-FDG PET with MRI for monitoring response to treatment in rheumatoid arthritis. Eur J Nucl Med Mol Imaging. 2010; 37(5):1047. PMC: 2854399. DOI: 10.1007/s00259-009-1364-x. View

17.

Verweij C . Predicting the future of anti-tumor necrosis factor therapy. Arthritis Res Ther. 2009; 11(3):115. PMC: 2714140. DOI: 10.1186/ar2724. View

18.

Kubota K, Yamashita H, Mimori A . Clinical Value of FDG-PET/CT for the Evaluation of Rheumatic Diseases: Rheumatoid Arthritis, Polymyalgia Rheumatica, and Relapsing Polychondritis. Semin Nucl Med. 2017; 47(4):408-424. DOI: 10.1053/j.semnuclmed.2017.02.005. View

19.

Yamashita H, Kubota K, Mimori A . Clinical value of whole-body PET/CT in patients with active rheumatic diseases. Arthritis Res Ther. 2015; 16(5):423. PMC: 4289312. DOI: 10.1186/s13075-014-0423-2. View

20.

Wakefield R, Green M, Marzo-Ortega H, Conaghan P, Gibbon W, McGonagle D . Should oligoarthritis be reclassified? Ultrasound reveals a high prevalence of subclinical disease. Ann Rheum Dis. 2004; 63(4):382-5. PMC: 1754934. DOI: 10.1136/ard.2003.007062. View